LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 81.05 | 84.90 | 4905 | 8863 | 0.5534 | 0.8311 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 81.05 | 84.90 | 3503 | 8863 | 0.3952 | 0.7414 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 81.05 | 84.90 | 5680 | 8863 | 0.6408 | 0.8716 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.75 | 84.90 | 221 | 8621 | 0.0256 | 0.1543 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.75 | 84.90 | 4975 | 8621 | 0.5771 | 0.8417 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.75 | 84.90 | 3090 | 8621 | 0.3584 | 0.7147 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.75 | 84.90 | 5813 | 8621 | 0.6742 | 0.8852 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 84.45 | 84.90 | 175 | 8254 | 0.0212 | 0.1158 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 84.45 | 84.90 | 5059 | 8254 | 0.6129 | 0.8571 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 84.45 | 84.90 | 2994 | 8254 | 0.3627 | 0.7153 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 84.45 | 84.90 | 5856 | 8254 | 0.7094 | 0.8987 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 86.16 | 84.90 | 178 | 8141 | 0.0219 | 0.1190 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 86.16 | 84.90 | 5154 | 8141 | 0.6330 | 0.8658 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 86.16 | 84.90 | 2502 | 8141 | 0.3073 | 0.6718 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 86.16 | 84.90 | 5997 | 8141 | 0.7366 | 0.9092 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 87.86 | 84.90 | 168 | 7680 | 0.0219 | 0.1107 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 87.86 | 84.90 | 5189 | 7680 | 0.6756 | 0.8829 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 87.86 | 84.90 | 2184 | 7680 | 0.2844 | 0.6482 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 87.86 | 84.90 | 6109 | 7680 | 0.7954 | 0.9308 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 89.57 | 84.90 | 143 | 7494 | 0.0191 | 0.0840 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 89.57 | 84.90 | 5256 | 7494 | 0.7013 | 0.8932 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 89.57 | 84.90 | 2078 | 7494 | 0.2773 | 0.6400 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 89.57 | 84.90 | 6191 | 7494 | 0.8261 | 0.9417 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 91.27 | 84.90 | 86 | 7420 | 0.0116 | 0.0020 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 91.27 | 84.90 | 5321 | 7420 | 0.7171 | 0.8995 | MN20160318_Q02 | K22 |